| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $41.5B | $34.9B | $31.4B | $26.5B | $21.3B | $21.3B | $3.6B | — |
| Cost of Revenue | $9.3B | $8.5B | $8.4B | $7.0B | $5.4B | $5.4B | $3.5B | — |
| Gross Profit | $32.3B | $26.3B | $23.0B | $19.5B | $15.8B | $15.8B | $2.7B | $2.1B |
| R&D Expense | $6.0B | $4.9B | $5.1B | $4.5B | $3.6B | $3.6B | $1.9B | $1.6B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $8.3B | $5.0B | $1.0B | $0.5B | $0.5B | $0.5B | $0.1B | $0.1B |
| Net Income | $7.5B | $4.1B | $0.2B | $1.4B | $4.1B | $4.1B | $0.4B | $0.1B |
| EPS (Basic) | $7.85 | $4.25 | $0.21 | $1.51 | $4.48 | $4.48 | $0.47 | $0.09 |
| EPS (Diluted) | $7.80 | $4.20 | $0.21 | $1.48 | $4.38 | $4.38 | $0.46 | $0.09 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $112.3B | $99.8B | $98.8B | $95.2B | $66.3B | $66.3B | $30.7B | $21.0B |
| Current Assets | $28.2B | $29.1B | $26.4B | $22.9B | $21.9B | $21.9B | $10.7B | $9.3B |
| Cash & Equivalents | $7.3B | $8.5B | $7.0B | $5.5B | $6.2B | $6.2B | $2.7B | $2.5B |
| Total Liabilities | $53.2B | $40.2B | $40.5B | $37.1B | $24.8B | $24.8B | $15.1B | $11.6B |
| Current Liabilities | $37.1B | $26.6B | $25.9B | $21.8B | $17.7B | $17.7B | $11.3B | $10.1B |
| Stockholders' Equity | $59.1B | $59.6B | $58.4B | $58.1B | $41.5B | $41.5B | $15.6B | $9.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $15.0B | $10.2B | $7.1B | $6.0B | $4.8B | $4.8B | $3.4B | $2.7B |
| Investing Cash Flow | $-8.6B | $-1.3B | $-2.0B | $-14.5B | $-4.0B | $-4.0B | $-5.3B | $-2.0B |
| Capital Expenditures | $0.6B | $0.7B | $0.8B | $0.7B | $0.7B | $0.7B | $0.6B | $0.5B |
| Financing Cash Flow | $-8.1B | $-7.5B | $-3.6B | $7.8B | $1.2B | $1.2B | $2.0B | $0.2B |